Objectif
Development of a novel strategy of vaccination against bovine herpesvirus 1 based on a suicide vaccine, which is able to perform only a single cycle of replication after intranasal inoculation. The vaccine combines the high immunogenic potential of a live vaccine and the safety of a killed vaccine.
Champ scientifique
Thème(s)
Data not availableAppel à propositions
Data not availableRégime de financement
RGI - Research grants (individual fellowships)Coordinateur
4000 Liege
Belgique